The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2

Liver Cancer

Volumn 5, Issue 1, 2016, Pages 8-20

  Lin, Chen Chun ^a   Cheng, Ya Ting ^a   Chen, M Wei Ting ^a   Lin, Shi Ming ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Barcelona Clinic Liver Cancer; Hepatocellular carcinoma; Multiple electrode; Radiofrequency ablation; Survival

Indexed keywords

AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84992170906     PISSN: 22351795     EISSN: 16645553     Source Type: Journal    
DOI: 10.1159/000367755     Document Type: Article

References (33)

1. Bruix J, Sherman, M Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
2. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M, HCC Expert Panel of Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011;29:339-364.
3. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130.
4. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
5. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-1156.
6. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS: Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-768.
7. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J, Barcelona Clínic Liver Cancer Group: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360.
8. Laeseke PF, Sampson LA, Haemmerich D, Brace CL, Fine JP, Frey TM, Winter TC 3rd, Lee FT Jr: Multipleelectrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 2006;241:116-124.
9. Laeseke PF, Sampson LA, Frey TM, Mukherjee R, Winter TC 3rd, Lee FT Jr, Brace CL: Multiple-electrode radiofrequency ablation: comparison with a conventional cluster electrode in an in vivo porcine kidney model. J Vasc Interv Radiol 2007;18:1005-1010.
10. Lee JM, Han JK, Kim HC, Kim SH, Kim KW, Joo SM, Choi BI: Multiple-electrode radiofrequency ablation of in vivo porcine liver: comparative studies of consecutive monopolar, switching monopolar versus multipolar modes. Invest Radiol 2007;42:676-683.
11. Brace CL, Sampson LA, Hinshaw JL, Sandhu N, Lee FT Jr: Radiofrequency ablation: simultaneous application of multiple electrodes via switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009;20:118-124.
12. Frericks BB, Ritz JP, Roggan A, Wolf KJ, Albrecht T: Multipolar radiofrequency ablation of hepatic tumors: initial experience. Radiology 2005;237:1056-1062.
13. Lee J, Lee JM, Yoon JH, Lee JY, Kim SH, Lee JE, Han JK, Choi BI: Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol 2012;13:34-43.
14. Seror O, N'Kontchou G, Ibraheem M, Ajavon Y, Barrucand C, Ganne N, Coderc E, Trinchet JC, Beaugrand M, Sellier N: Large (or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes-initial experience in 26 patients. Radiology 2008;248:288-296.
15. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, Raoul JL, Sangro B: Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 2012;32:348-359.
16. Ritz JP, Lehmann KS, Reissfelder C, Albrecht T, Frericks B, Zurbuchen U, Buhr HJ: Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept. Int J Colorectal Dis 2006;21:25-32.
17. Lencioni R, Crocetti L: Local-regional treatment of hepatocellular carcinoma. Radiology 2012;262:43-58.
18. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
19. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK: Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-474.
20. Tsurusaki M, Murakami T: Surgical and Locoregional Therapy of HCC: TACE. Liver Cancer 2015;4:165-175.
21. Lin SM: Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83.
22. Kang TW, Rhim H: Recent advances in tumor ablation for hepatocellular carcinoma. Liver Cancer 2015;4:176-187.
23. Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY: Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 2008;17:23-31.
24. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K: Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-577, quiz 578.
25. Kim JH, Kim PN, Won HJ, Shin YM: Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma. Am J Roentgenol 2012;198:471-476.
26. Park MJ, Kim YS, Rhim H, Lim HK, Lee MW, Choi D: A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique. J Vasc Interv Radiol 2011;22:771-779.
27. Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, Dai Y: Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 2004;232:260-271.
28. Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Tai MH, Liu HC, Liu C: Thrombocytopenia as an inexpensive, valuable predictor for survival in patients with hepatocellular carcinoma. Scand J Gastroenterol 2014;49:1507-1508.
29. Santambrogio R, Opocher E, Costa M, Barabino M, Zuin M, Bertolini E, De Filippi F, Bruno S: Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein. Ann Surg Oncol 2012;19:426-434.
30. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
31. Song I, Rhim H, Lim HK, Kim YS, Choi D: Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 2009;19:2630-2640.
32. Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, Tanihata H, Kimura M, Takeuchi N: Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009;32:62-69.
33. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY: Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013;31:426-432.